compatibility with brain tissue and reducing risks associated with long-term implantation. Its devices are designed to access broader regions of the cortex through minimally invasive procedures while supporting neural recording and stimulation capabilities. Neurosoft Bioelectronics also integrates artificial intelligence into its platform to analyze brain signals, detect biomarkers, and assist in decoding motor and speech intentions for neurological applications. The company is conducting clinical studies and developing implantable systems intended for conditions such as epilepsy, neurological disorders, and other brain-related impairments.